XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue:    
Total revenue $ 7,193 $ 22,305
Costs and expenses:    
Cost of product revenue   21,010
Research and development 14,153 25,715
Selling, general and administrative 24,830 30,625
Impairment of property and equipment 2,511 151
Total costs and expenses 56,857 77,501
Loss from operations (49,664) (55,196)
Other income (expense):    
Interest expense to related party (5,343) (6,084)
Change in fair value of derivative related to Term Loan with related party (466) (1,088)
Change in fair value of warrant liabilities 5,891 326
Other, net (495) 39
Total other income (expense) (413) (6,807)
Net loss (50,077) (62,003)
Deemed dividend on Series A Redeemable Convertible Preferred Stock   (330)
Net loss attributable to common stockholders $ (50,077) $ (62,333)
Net loss per share - basic $ (19.19) $ (1,222.14)
Net loss per share - diluted $ (19.19) $ (1,222.14)
Weighted-average number of common shares used in computing net loss per share - basic 2,609,984 51,003
Weighted-average number of common shares used in computing net loss per share - diluted 2,609,984 51,003
Other comprehensive loss:    
Net Income (Loss) $ (50,077) $ (62,003)
Net unrealized gain on marketable securities arising during the period   2
Net realized gain on marketable securities included in net loss   2
Total other comprehensive income, net of taxes   4
Comprehensive loss (50,077) (61,999)
Product [Member]    
Revenue:    
Total revenue 6,770 11,259
Costs and expenses:    
Cost of product revenue 15,363 21,010
Contribution [Member]    
Revenue:    
Total revenue $ 423 $ 11,046